Antmen, B. Et Al. 2016. Defibrotide for the prevention and treatment of hepatic veno-occlusive disease after hematopoietic stem cell transplantation; A single center experience. 42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation , (Valencia, Spain).

Antmen, B., Sasmaz, I., Karagun, B., & Serbest, M., (2016). Defibrotide for the prevention and treatment of hepatic veno-occlusive disease after hematopoietic stem cell transplantation; A single center experience . 42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, Spain

Antmen, İBRAHİM Et Al. "Defibrotide for the prevention and treatment of hepatic veno-occlusive disease after hematopoietic stem cell transplantation; A single center experience," 42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation, Valencia, Spain, 2016

Antmen, İBRAHİM A. Et Al. "Defibrotide for the prevention and treatment of hepatic veno-occlusive disease after hematopoietic stem cell transplantation; A single center experience." 42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation , Valencia, Spain, 2016

Antmen, B. Et Al. (2016) . "Defibrotide for the prevention and treatment of hepatic veno-occlusive disease after hematopoietic stem cell transplantation; A single center experience." 42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation , Valencia, Spain.

@conferencepaper{conferencepaper, author={İBRAHİM ATİLLA ARIDOĞAN Et Al. }, title={Defibrotide for the prevention and treatment of hepatic veno-occlusive disease after hematopoietic stem cell transplantation; A single center experience}, congress name={42nd Annual Meeting of the European-Society-for-Blood-and-Marrow-Transplantation}, city={Valencia}, country={Spain}, year={2016}}